Recombinant follicle-stimulating hormone versus human menopausal gonadotropin in the late follicular phase during ovarian hyperstimulation for in vitro fertilization

By Commenges-Ducos M.   Piault S.   Papaxanthos A.   Ribes C.   Dallay D.   Commenges D.  

Fertility and Sterility, Vol. 78, Iss. 5, 2002-11 ,pp. : 1049-1054

Elsevier

Access to resources Recommend Favorite

Human menopausal gonadotropin versus recombinant follicle-stimulating hormone in normogonadotropic women down-regulated with a gonadotropin-releasing hormone agonist who were undergoing in vitro fertilization and intracytoplasmic sperm injection: a prospective randomized study

By Westergaard L.G.   Erb K.   Laursen S.B.   Rex S.   Rasmussen P.E.  

Fertility and Sterility, Vol. 76, Iss. 3, 2001-09 ,pp. : 543-549

Elsevier

Access to resources Recommend Favorite

Ovarian response and in vitro fertilization outcome in patients with reduced ovarian reserve who were stimulated with recombinant follicle-stimulating hormone or human menopausal gonadotropin

By Meo F.   Ranieri D.M.   Khadum I.   Serhal P.  

Fertility and Sterility, Vol. 77, Iss. 3, 2002-03 ,pp. : 630-632

Elsevier

Access to resources Recommend Favorite

Heterotopic pregnancy following administration of human menopausal gonadotropin and following in vitro fertilization and embryo transfer: two case reports and review of the literature

By Botta G.   Fortunato N.   Merlino G.  

European Journal of Obstetrics & Gynecology and Reproductive Biology, Vol. 59, Iss. 2, 1995-04 ,pp. : 211-215

Elsevier

Access to resources Recommend Favorite

Serum human chorionic gonadotropin levels are correlated with body mass index rather than route of administration in women undergoing in vitro fertilization-embryo transfer using human menopausal gonadotropin and intracytoplasmic sperm injection

By Elkind-Hirsch K.E.   Bello S.   Esparcia L.   Phillips K.   Sheiko A.   McNichol M.  

Fertility and Sterility, Vol. 75, Iss. 4, 2001-04 ,pp. : 700-704

Elsevier

Access to resources Recommend Favorite